Griffith University

BEc, MPH, PhD
Senior Research Fellow Heath Economics

Visiting Scientist QIMR
Honarary Fellow QUT School of Public Health

Contact Details for Dr Louisa Gordon

Biography

Dr Louisa Gordon is a Senior Research Fellow within the Centre for Applied Health Economics, School of Medicine, Griffith University. Dr Gordon has previously worked in the fields of finance, public health and health services research.  Her interests lay in developing a career in economic evaluations and to date, this has been focused in the field of supportive cancer care.

Most recently, Louisa has published in the areas of oesophageal, ovarian and skin cancer and currently leads an ARC Discovery project involving employment outcomes following a diagnosis of colorectal cancer. She currently holds NHMRC Postdoctoral Public Health Fellowship until December 2012.  Dr Gordon also has a visiting scientist appointment with QIMR and is a Honorary Fellow at QUT.

Research interests

• Cost-effectiveness of public health interventions
• Cost-effectiveness of cancer control interventions
• Cost analyses in health care
  

Publications

Book chapters

• Gordon LG. (2008) "Economics of basal and squamous cell skin cancers and related conditions" in Basal Cell Carcinoma, Squamous Cell Carcinoma (and related lesions) – A Guide to Clinical Management in Australia. Chapter 15.
• Gordon LG, Nagle C, Webb PM (2008) "Epidemiology" in Women’s Cancers, Blackwell Publishing Ltd.

Refereed journal articles

• Gordon L, Hirst NG, Green AC, Neale RE (2012) Tanning Behaviors and Determinants of Solarium use Among Indoor Office Workers in Queensland, Australia. Journal of Health Psychology. (epub ahead of print)
• Hirst NG, Gordon LG, Scuffham PA, Green AC (2012) Lifetime Cost-Effectiveness of Skin Cancer Prevention through Promotion of Daily Sunscreen Use. Value in Health. 15(2):261-268.
• Gordon LG, Lynch BM, Beesley VL, Graves N, McGrath C, O'Rourke P, Webb PM (2011) The Working After Cancer Study (WACS): a population-based study of middle-aged workers diagnosed with colorectal cancer and their return to work experiences. BMC Public Health.  11(1):1-5.
• Newton MJ, Hayes SC, Janda M, Webb PM, Obermair A, Eakin EG, Wyld D, Gordon LG, Beesley VL (2011) Safety, feasibility and effects of an individualised walking intervention for women undergoing chemotherapy for ovarian cancer: a pilot study. BMC Cancer. 11(1):1-9.
• Hirst NG, Gordon LG, Whiteman DC, Watson DI, Barendregt JJ (2011) Is endoscopic surveillance for non-dysplastic Barrett's esophagus cost-effective? Review of economic evaluations. Journal of Gastroentorology and Hepatology. 26(2):247-254.
• Gordon LG, Eckermann S, Hirst N, Watson DI, Mayne GC,  Fahey P, Whiteman DC for the Australian Cancer Study Clinical Follow-Up Study 2010 (2011) Health care resource use and medical costs for managing oesophageal cancer. British Journal of Surgery. 98(11):1589-1598.
• Janda M, Neale RE, Youl P, Whiteman DC, Gordon LG, Baade PD (2011) Impact of a video-based intervention to improve the prevalence of skin-self examination  in men 50 years or older: the randomized Skin Awareness trial. Archives Dermatology. 147(7):799-806.
• Gordon LG, Beesley VL, Scuffham PA (2011) Evidence on the economic value of psychosocial interventions to alleviate anxiety and depression among cancer survivors.  Asia-Pacific Journal of Clinical Oncology. 7(2):96–105.
• Kondalsamy-Chennakesavan S, Gordon LG, Sanday K, Bouman C, De Jong S, Nicklin J, Land R, Obermair A (2011) Hospital costs associated with adverse events in gynecological oncology. Gynecologic Oncology. 121(1):70-5.
• Gies P, Javorniczky J, Henderson S, McLennan A, Roy C, Lock J, Lynga C, Gordon L (2011) UVR emissions from solaria in Australia and implications for the regulation process. Photochem Photobiol. 87(1):184-190.
• Gordon LG, Hirst N, Young R, Brown P (2010) Within a smoking-cessation program, what impact does genetic information on lung cancer need to have to demonstrate cost-effectiveness? Cost-effectiveness and Resource Allocation. 8(18).
• Gordon LG, Scuffham PA, Beesley VL, Green AC, DeFazio A, Wyld DK, Clavarino AM, Australian Ovarian Cancer Study Group, Webb PM (2010) Medical costs and outcomes for Australian women with ovarian cancer: a patient-level analysis over 2½ years. International Journal of Gyne Cancer. 20(5):757-765.
• Gordon LG, Obermair A (2010) Potential cost-savings attributed to improvements in outcomes for colorectal cancer surgery following self-audit. BMC Surgery. 10(4).
• Janda M, Baade PD, Youl PH, Aitken JF, Whiteman DC, Gordon L, Neale RE (2010) The Skin Awareness Study: Promoting thorough skin self-examination for skin cancer among men 50 years or older. Contemporary Clinical Trials. 31(1):119-130.
• Gordon LG, Ferguson M, Chambers SK, Dunn J (2009) Fuel, beds, meals and meds: out-of-pocket expenses for patients with cancer in rural Queensland. Cancer Forum. 33(3): 202-208.
• Gordon LG, Scuffham PA, van der Pols JC, McBride P, Williams G, Green AC (2009) Regular sunscreen use is a cost-effective approach to skin cancer prevention in sub-tropical settings. Journal of Invest Dermatology. 129; 2766-2771.
• Hirst N, Gordon LG, Gies P, Green AC (2009) Estimation of avoidable skin cancers and cost-savings to government associated with regulation of the solarium industry in Australia’. Health Policy. 89; 303-311.
• Hawkes AL, Pakenham KI, Courneya KS, Golleschewski S, Baade P, Gordon LG, Lynch BM, Aitken JF, Chambers SK (2009) A randomised controlled trial of a tele-based lifestyle intervention for colorectal cancer survivors (CanChange) study protocol. BMC Cancer. 9:286.
• Gordon LG, Lynch BM, Newman B (2008) Transitions in work participation before and after a diagnosis of colorectal cancer. ANZ Journal of Public Health. 32(6): 569-574.
• Gordon LG, Hirst N, Gies P, Green AC (2008) What impact would effective solarium regulation have in Australia? Medical Journal of Australia. 189(7): 375-378.
• Chambers SK, Schover L, Halford K, Clutton S,  Ferguson M, Gordon L, Gardiner RA, Occhipinti S, Dunn J (2008) ProsCan for Couples: Randomised controlled trial of a couples-based sexuality intervention for men with localised prostate cancer who receive radical prostatectomy. BMC Cancer. 8:226.
• Chambers SK, Ferguson M, Gardiner RA, Nicol D, Gordon L, Occhipinti S, Aitken J (2008) ProsCan for Men: Randomised controlled trial of a decision support intervention for men with localised prostate cancer. BMC Cancer. 8:207.
• Gordon LG, Graves N, Eakin E (2007) Cost effectiveness of face-to-face health behaviour interventions for smoking, physical activity, dietary intake and alcohol. Chronic Illness. 3;101.
• Gordon LG, Youl PH, Janda M, Aitken JF (2007) Diagnosis and management costs of suspicious skin lesions from population-based community melanoma skin screening clinics. Journal of Med Screening. 14:2; 98-102.
• Gordon LG, Scuffham PA, Hayes S, Newman B (2007) Exploring the economic impact to younger and older breast cancer survivors during the 18 months following diagnosis. Psycho-Oncology. 16: 1-10.
• Gordon L, Edwards H, Courtney M, Finlayson K, Shuter P (2006) A cost-effectiveness analysis of two community models of nursing care for managing chronic venous leg ulcers. Journal of Wound Care. 15(8):348-353.
• Graves N, McKinnon L, Reeves M, Scuffham P, Gordon LG, Eakin E (2006) Cost-effectiveness analyses and modelling the lifetime costs and benefits of health-behaviour interventions.Chronic Illness. 2: 97-107.
• Gordon LG, Battistutta D, Scuffham P, Newman B (2005) Cost-effectiveness of two rehabilitation programs for women with breast cancer. Breast Cancer Research & Treatment. 94:123-133.